Skip to main content
Equibles

Phocas Financial Corp.

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1356783 ALAMEDA, CA
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$1,954,298
+$143,514 QoQ
Shares Held
77,245
-5.0% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#120
of 354 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 16% Shared 0% None 84%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Phocas Financial Corp. holds $23,102,138 across 10 Biotechnology names. ACAD ranks #6 (8.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZVRA
Zevra Therapeutics, Inc.
 295,907 $4,243,306
2 PTCT
Ptc Therapeutics, Inc.
 46,170 $3,766,086
3 NRIX
Nurix Therapeutics, Inc.
 99,589 $2,416,029
4 CYTK
Cytokinetics Inc
 24,634 $2,098,570
5 PTGX
Protagonist Therapeutics, Inc
 16,378 $2,007,615
6 ACAD
Acadia Pharmaceuticals Inc
This page 		77,245 $1,954,298
7 DNLI
Denali Therapeutics Inc.
 71,197 $1,831,186
8 IDYA
IDEAYA Biosciences, Inc.
 48,822 $1,819,595

All Filings in ACAD

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,954,298 77,245
2026-03-31 $1,810,784 81,347
2025-12-31 $2,779,763 104,072
2025-09-30 $2,226,679 104,343
2025-06-30 $2,203,936 102,176
2025-03-31 $1,696,894 102,161
2024-12-31 $1,978,331 107,811
2024-09-30 $926,106 60,215
2024-06-30 $1,039,951 63,997
2024-03-31 $1,205,677 65,207
2023-12-31 $2,096,423 66,957
2023-09-30 $1,369,000 65,691